Cytori Therapeutics Inc (CYTX) Scheduled to Post Earnings on Thursday
Cytori Therapeutics Inc (NASDAQ:CYTX) will post its quarterly earnings results after the market closes on Thursday, August 10th. Analysts expect Cytori Therapeutics to post earnings of ($0.16) per share for the quarter.
Cytori Therapeutics (NASDAQ:CYTX) last announced its earnings results on Thursday, May 11th. The biotechnology company reported ($0.26) EPS for the quarter, beating analysts’ consensus estimates of ($0.31) by $0.05. Cytori Therapeutics had a negative return on equity of 177.92% and a negative net margin of 491.71%. The company had revenue of $0.60 million during the quarter, compared to analysts’ expectations of $2.32 million. During the same period last year, the business posted ($0.03) EPS. Cytori Therapeutics’s revenue for the quarter was down 53.8% on a year-over-year basis. On average, analysts expect Cytori Therapeutics to post $-0.64 EPS for the current fiscal year and $-0.12 EPS for the next fiscal year.
Shares of Cytori Therapeutics Inc (NASDAQ CYTX) traded down 4.87548% during trading on Monday, reaching $0.37051. The company had a trading volume of 67,055 shares. The firm’s market capitalization is $12.03 million. The firm has a 50-day moving average of $0.95 and a 200 day moving average of $1.27. Cytori Therapeutics Inc has a 52 week low of $0.36 and a 52 week high of $2.29.
Several brokerages have commented on CYTX. ValuEngine upgraded Cytori Therapeutics from a “strong sell” rating to a “sell” rating in a research note on Thursday, July 13th. Zacks Investment Research lowered Cytori Therapeutics from a “buy” rating to a “hold” rating in a research note on Wednesday, July 12th. Maxim Group set a $10.00 price target on Cytori Therapeutics and gave the stock a “buy” rating in a research note on Monday, July 10th. Finally, B. Riley restated a “buy” rating and set a $2.30 price target on shares of Cytori Therapeutics in a research note on Monday, May 15th.
Cytori Therapeutics Company Profile
Cytori Therapeutics, Inc (Cytori) is a biotechnology company engaged in the development of treatments and devices for a range of disorders using cells as a key part of the therapy. The Company develops cellular therapeutics formulated and optimized for specific diseases and medical conditions and related products.
Receive News & Ratings for Cytori Therapeutics Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cytori Therapeutics Inc and related companies with MarketBeat.com's FREE daily email newsletter.